# Gladius Pharmaceuticals Corp — Form D

Gladius Pharmaceuticals Corp of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2018-11-28. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-11-28
- Form: D
- Accession: 0001646819-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 5
- Date of first sale: 2018-11-14
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-326665

## Issuer

- Name: Gladius Pharmaceuticals Corp
- CIK: 0001646819
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 2711 CENTERVILLE ROAD, SUITE 400, WILMINGTON, DE, 19808
- Phone: 514-213-4456

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Nathalie Chauret | Director | Wilmington, DE |
| Jens Eckstein | Director | Cambridge, MA |
| Daniel Hetu | Director | Montreal, A8 |
| Larry Sutton | Director | Wilmington, DE |
| Michael Atkin | Executive Officer | Kirkland, A8 |
| Michael Atkin | Director | Kirkland, A8 |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2015-06-30](https://search.stillhousedata.com/formd/0001144204-15-040067) | D | $728K | $728K |

## More

- [CIK 1646819 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1646819&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001646819-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.